![]() | |
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C26H27NO2 |
Molar mass | 385.507 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
JWH-098 is a syntheticcannabinoid receptoragonist from thenaphthoylindole family. It is theindole 2-methyl derivative of a closely related compoundJWH-081, but has markedly different affinity for theCB1 andCB2 receptors. While JWH-081 is around tenfold selective for CB1 over CB2, in JWH-098 this is reversed, and it is around four times weaker than JWH-081 at CB1 while being six times more potent at CB2, giving it a slight selectivity for CB2 overall. This makes JWH-098 a good example of how methylation of the indole 2-position in the naphthoylindole series tends to increase CB2 affinity, but often at the expense of CB1 binding.[2]
In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-098 areSchedule I Controlled Substances.[3]
JWH-098 is illegal in Russia,[4] Sweden,[5] and the UK,[6] although it is unclear whether it has any history of human use.
![]() | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |